GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | BCL2L11 | increases expression | EXP | | 6480464 | CTD | vorinostat results in increased expression of BCL2L11 mRNA; vorinostat results in increased expression of BCL2L11 protein; vorinostat results in increased expression of BCL2L11 protein alternative form | PMID:16144943 PMID:17351739 PMID:19509267 PMID:21652541 | BCL2L11 | multiple interactions | EXP | | 6480464 | CTD | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2L11 mRNA; TNFSF10 protein promotes the reaction [Vorinostat results in increased expression of BCL2L11 mRNA]; TNFSF10 protein promotes the reaction [Vorinostat results in increased expression of BCL2L11 protein] | PMID:19509267 PMID:27188386 | BCL2L11 | increases expression | ISO | Bcl2l11 (Rattus norvegicus) | 6480464 | CTD | vorinostat results in increased expression of BCL2L11 mRNA; vorinostat results in increased expression of BCL2L11 protein | PMID:17331788 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |